CERO
Price
$0.78
Change
+$0.08 (+11.43%)
Updated
Apr 9, 04:25 PM (EDT)
Capitalization
2.14M
IMRN
Price
$1.70
Change
-$0.02 (-1.16%)
Updated
Apr 9, 04:17 PM (EDT)
Capitalization
8.64M
49 days until earnings call
Ad is loading...

CERO vs IMRN

Header iconCERO vs IMRN Comparison
Open Charts CERO vs IMRNBanner chart's image
CERo Therapeutics Holdings
Price$0.78
Change+$0.08 (+11.43%)
Volume$1.19K
Capitalization2.14M
Immuron
Price$1.70
Change-$0.02 (-1.16%)
Volume$100
Capitalization8.64M
CERO vs IMRN Comparison Chart
Loading...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERO vs. IMRN commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERO is a Hold and IMRN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (CERO: $0.70 vs. IMRN: $1.72)
Brand notoriety: CERO and IMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CERO: 51% vs. IMRN: 52%
Market capitalization -- CERO: $2.14M vs. IMRN: $8.64M
CERO [@Biotechnology] is valued at $2.14M. IMRN’s [@Biotechnology] market capitalization is $8.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERO’s FA Score shows that 1 FA rating(s) are green whileIMRN’s FA Score has 1 green FA rating(s).

  • CERO’s FA Score: 1 green, 4 red.
  • IMRN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CERO and IMRN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERO’s TA Score shows that 3 TA indicator(s) are bullish.

  • CERO’s TA Score: 3 bullish, 2 bearish.

Price Growth

CERO (@Biotechnology) experienced а -2.08% price change this week, while IMRN (@Biotechnology) price change was -1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.87%. For the same industry, the average monthly price growth was -11.06%, and the average quarterly price growth was -15.27%.

Reported Earning Dates

CERO is expected to report earnings on Mar 24, 2023.

IMRN is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-4.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRN($8.64M) has a higher market cap than CERO($2.14M). IMRN YTD gains are higher at: 1.176 vs. CERO (-88.250). IMRN has more cash in the bank: 7.74M vs. CERO (3.38M).
CEROIMRNCERO / IMRN
Capitalization2.14M8.64M25%
EBITDAN/A-7.35M-
Gain YTD-88.2501.176-7,501%
P/E RatioN/AN/A-
RevenueN/A6.54M-
Total Cash3.38M7.74M44%
Total Debt1.81MN/A-
FUNDAMENTALS RATINGS
IMRN: Fundamental Ratings
IMRN
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CERO
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
N/A
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 21 days ago
50%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY496.48-7.90
-1.57%
SPDR® S&P 500® ETF
GME23.39-0.90
-3.71%
GameStop Corp
BTC.X76271.950000-2963.382800
-3.74%
Bitcoin cryptocurrency
TSLA221.86-11.43
-4.90%
Tesla
AAPL172.42-9.04
-4.98%
Apple

CERO and

Correlation & Price change

A.I.dvisor tells us that CERO and IBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CERO and IBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
-0.70%
IBIO - CERO
30%
Poorly correlated
N/A
BRTX - CERO
30%
Poorly correlated
+3.53%
KALV - CERO
27%
Poorly correlated
-10.26%
IMRN - CERO
26%
Poorly correlated
-0.58%
GOVX - CERO
24%
Poorly correlated
+1.89%
More

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with RIGL. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
-0.58%
RIGL - IMRN
82%
Closely correlated
-3.93%
CLNN - IMRN
80%
Closely correlated
+7.52%
HOOK - IMRN
79%
Closely correlated
-7.83%
AZTR - IMRN
72%
Closely correlated
-2.06%
PHIO - IMRN
72%
Closely correlated
-1.94%
More